Pharmacology of NMDA receptors

Glutamate and GABA Receptors and Transporters: Structure, Function and Pharmacology

Volumn , Issue , 2001, Pages 69-98

  Jane, David ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0013122808     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (150)

1. Aebischer, B., Frey, P., Haerter, H.P., Herrling, P.L., Mueller, W.A., Olverman, H.J. and Watkins, J.C. (1989) ‘Synthesis and NMDA antagonist properties of the enantiomers of 4-(3-phosphonopropyl)piperazine-2-carboxylic acid (CPP) and of the unsaturated analogue (E)-4-(3-phosphonoprop-2-enyl)piperazine-2-carboxylic acid (CPP-ene)', Helv. Chim. Acta 72: 1043-1051.
2. Allan, R.D., Hanrahan, J.R., Hambley, T.W., Johnston, G.A.R., Mewett, K.N. and Mitrovic, A.D. (1990) ‘Synthesis and activity of a potent N-methyl-D-aspartic acid agonist, trans-1-aminocyclobutane-1,3-dicarboxylic acid, and related phosphonic and carboxylic acids’, J. Med. Chem. 33: 2905-2915.
3. Anis, N.A., Berry, S.C., Burton, N.R. and Lodge, D. (1983) ‘The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurons by N-methyl-D- aspartate’, Br. J. Pharmacol. 79: 565-575.
4. Auberson, Y.P., Acklin, P., Bischoff, S., Moretti, R., Ofner, S., Schmutz, M. and Veenstra, S.J. (1999) ‘N-phosphonoalkyl-5-aminomethylquinoxaline-2,3-diones: in vivo active AMPA and NMDA (glycine) antagonists’, Bioorg. Med. Chem. Lett. 9: 249-254.
5. Avenet, P., Léonardon, J., Besnard, F., Graham, D., Depoortere, H. and Scatton, B. (1997) ‘Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes’, Neurosci. Lett. 223: 133-136.
6. Balcar, V.J. and Johnston, G.A.R. (1972) ‘The structural specificity of the high affinity uptake of L-glutamate and L-aspartate by rat brain slices’ J. Neurochem. 19: 2657-2666.
7. Balsamini, C., Bedini, A., Diamantini, G., Spadoni, G., Tontini, A., Tarzia, G., Di Fabio, R., Feriani, A., Reggiani, A., Tedesco, G. and Valigi, R. (1998) '(E)-3-(2-(N-Phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists’, J. Med. Chem. 41: 808-820.
8. Baudy, R.B., Greenblatt, L.P., Jirkovsky, I.L., Conklin, M., Russo, R.J., Bramlett, D.R., Emrey, T.A., Simmonds, J.T., Kowal, D.M., Stein, R.P. and Tasse, R.P. (1993) ‘Potent quinoxalinespaced phosphono a-amino acids of the AP6 type as competitive NMDA antagonists: synthesis and biological evaluation’, J. Med. Chem. 36: 331-342.
9. 3H]CGP 61594, the first photoaffinity ligand for the glycine site of NMDA receptors’, Neuropharmacology 38: 233-242.
10. Benveniste, M. and Mayer, M.L. (1993) ‘Multiple effects of spermine on N-methyl-D-aspartic acid receptor responses of rat cultured hippocampal neurons’, J. Physiol. 464: 131-163.
11. Bernardi, M., Bertolini, A., Szczawinska, K. and Genedani, S. (1996) ‘Blockade of the polyamine site of NMDA receptors produces antinociception and enhances the effect of morphine, in mice’, Eur. J. Pharmacol. 298: 51-55.
12. Bigge, C.F. (1993) ‘Structural requirements for the development of potent N-methyl-D-aspartic acid (NMDA) receptor antagonists’, Biochemical Pharmacology 45: 1547-1561.
13. Bigge, C.F., Malone, T.C., Boxer, P.A., Nelson, C.B., Ortwine, D.F., Schelkun, R.M., Retz, D.M., Lescosky, L.J., Borosky, S.A., Vartanian, M.G., Schwarz, R.D., Campbell, G.W., Robichaud, L.J. and Wätjen, F. (1995) ‘Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]-quinox-aline-2,3-dione and related quinoxalinediones: characterisation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity’, J. Med. Chem. 38: 3720-3740.
14. Birch, P.J., Grossman, C.J. and Hayes, A.G. (1988) ‘Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor’, Eur. J. Pharmacol. 154: 85-87.
15. Biscoe, T.J., Davies, J, Dray, A., Evans, R.H., Francis, A.A., Martin, M.R. and Watkins, J.C. (1977a) ‘Depression of synaptic excitation and of amino acid-induced excitatory responses of spinal neurones by D-α-aminoadipate, α,∈-diaminopimelic acid and HA-966', Eur. J. Pharmacol. 45: 315-316.
16. Biscoe, T.J., Evans, R.H., Francis, A.A., Martin, M.R., Watkins, J.C., Davies, J. and Dray, A. (1977b) ‘D-α-aminoadipate as a selective antagonist of amino acid-induced and synaptic excitation of mammalian spinal neurones’, Nature, 270: 743-745.
17. Blanpied, T.A., Boeckman, F.A., Aizenman, E. and Johnson, J.W. (1997) ‘Trapping channel block of NMDA-activated responses by amantadine and memantine’, J. Neurophysiol. 77: 309-323.
18. Bordi, F., Quartaroli, M., Reggiani, A. and Trist, D.G. (1998) ‘Suppression of noxious stimulusevoked activity by the glycine site antagonist GV196771A in the posterolateral nucleus of the thalamus of rats with an experimental peripheral mononeuropathy’, Naunyn-Schmeidbergs Archives of Pharmacology 358: 1120.
19. Bräuner-Osborne, H., Nielsen, B., Stensbøl, T.B., Johansen, T.N., Skjærbæk, N. and Krogsgaard-Larsen, P. (1997) ‘Molecular pharmacology of 4-substituted glutamic acid analogues at ionotropic and metabotropic excitatory amino acid receptors’, Eur. J. Pharmacol. 335: R1-R3.
20. 3H]Homoquinolinate binds to a subpopulation of NMDA receptors and to a novel binding site’, J. Neurochem. 71: 1464-1470.
21. Buller, A.L., Larson, H.C., Schneider, B.E., Beaton, J.A., Morrisett, R.A. and Monaghan, D.T. (1994) ‘The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition’, J. Neurosci. 14: 5471-5484.
22. Buller, A.L. and Monaghan, D.T. (1997) ‘Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes’, Eur. J. Pharmacol. 320: 87-94.
23. Butler, T.W., Blake, J.F., Bordner, J., Butler, P., Chenard, B.L., Collins, M.A., DeCosta, D., Ducat, M.J., Eisenhard, M.E., Menniti, F.S., Pagnozzi, M.J., Sands, S.B., Segelstein, B.E., Volberg, W., White, W.F. and Zhao, D. (1998) '(3R,4S)-3-[4-(4-Fluorophenyl)-4-hydroxypiperidibn-1-yl]chroman-4,7-diol: a conformationally restricted analogue of the NR2B subtype-selective NMDA antagonist (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol’, J. Med. Chem. 41: 1172-1184.
24. Cai, S.X., Kehr, S.M., Zhou, Z.-L., Ilyin, V., Espitia, S.A., Tran, M., Hawkinson, J.E., Woodward, R.M., Weber, E. and Keana, J.F.W. (1997) ‘Structure-activity relationships of alkyl- and alkoxysubstituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor’, J. Med. Chem. 40: 730-738.
25. Carignani, C., Ugolini, A., Pinnola, V., Belardetti, F., Trist, D.G. and Corsi, M. (1998) ‘NMDA receptor subunit characterization of the glycine site antagonist GV196771A and its action on the spinal cord wind-up’, Naunyn-Schmeidbergs Archives of Pharmacology 358: 1119.
26. Carter, C., Rivy, J.P. and Scatton, B. (1989) ‘Ifenprodil and SL-82.0715 are antagonists at the polyamine site of the N-methyl-D-aspartate (NMDA) receptor’, Eur. J. Pharmacol. 164: 611-612.
27. Catarzi, D., Colotta, V., Varano, F., Cecchi, L., Filacchioni, G., Galli, A. and Costagli, C. (1999) '4,5-Dihydro-1,2,4-triazolo[1,5-a]quinoxalin-4-ones: excitatory amino acid antagonists with combined glycine/NMDA and AMPA receptor affinity’, J. Med. Chem. 42: 2478-2484.
28. Chandler, P., Pennington, M., Maccecchini, M.-L., Nashed, N.T. and Skolnick, P. (1993) ‘Polyamine-like action of peptides derived from conantokin-G, an N-methyl-D-aspartate (NMDA) antagonist’, J. Biol. Chem. 268: 17,173-17,178.
29. Chenard, B.L., Bordner, J., Butler, T.W., Chambers, L.K., Collins, M.A., Decosta, D.L., Ducat, M.F., Dumont, M.L., Fox, C.B., Mena, E.E., Menniti, F.S., Nielsen, J., Pagnozzi, M.J., Richter, K.E.G., Ronau, R.T., Shalaby, I.A., Stemple, J.Z. and White, W.F. (1995) '(1S,2S)-1-(4-Hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol - a potent new neuroprotectant which blocks N-methyl-D-aspartate responses’, J. Med. Chem. 38: 3138-3145.
30. 2+ channels in rat and mouse cultured hippocampal pyramidal neurons - comparison with N-methyl-D-aspartate receptor antagonist actions’, Br. J. Pharmacol. 113: 499-507.
31. Collingridge, G.L. and Lester, R.A.J. (1989) ‘Excitatory amino acid receptors in the vertebrate central nervous system’, Pharmacological Reviews 40: 143-210.
32. Cordi, A., Lacoste, J.-M., Audinot, V. and Millan, M. (1999) ‘Design, synthesis and structure-activity relationships of novel strychnine-insensitive glycine receptor ligands’, Bioorg. Med. Chem. Lett. 9: 1409-1414.
33. Croucher, M.J., Collins, J.F. and Meldrum, B.S. (1982) ‘Anticonvulsant action of excitatory amino acid antagonists’, Science 216: 899-901.
34. Curtis, D.R. and Watkins, J.C. (1960) ‘The excitation and depression of spinal neurones by structurally related amino acids’, J. Neurochem. 6: 117-141.
35. Curtis, D.R. and Watkins, J.C. (1963) ‘Acidic amino acids with strong excitatory actions on mammalian neurones’, J. Physiol. 166: 1-14.
36. Das, S., Sasaki, Y.F., Rothe, T., Premkumar, L.S., Takasu, M., Crandall, J.E., Dikkes, P., Conner, D.A., Rayudu, P.V., Cheung, W., Vincent Chen, H.-S., Lipton, S.A. and Nakanishi, N. (1998) ‘Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A’, Nature (Lond.) 393: 377-381.
37. 3H]D-AP5 binding sites on brain membranes and anticonvulsant activity’, Brain Research 382: 169-173.
38. Di Fabio, R., Capelli, A.M., Conti, N., Cugola, A., Donati, D., Feriani, A., Gastaldi, P., Gaviraghi, G., Hewkin, C.T., Micheli, F., Missio, A., Mugnaini, M., Pecunioso, A., Quaglia, A.M., Ratti, E., Rossi, L., Tedesco, G., Trist, D.G. and Reggiani, A. (1997) ‘Substituted indole-2-carboxylates as in vivo potent antagonists acting at the strychnine-insensitive glycine binding site’, J. Med. Chem. 40: 841-850.
39. Dingledine, R., Borges, K., Bowie, D. and Traynelis, S.F. (1999) ‘The glutamate receptor ion channels’, Pharmacological Reviews 51: 7-61.
40. Donevan, S.D., Beg, A., Gunther, J.M. and Twyman, R.E. (1998) ‘The methylglutamate, SYM 2081, is a potent and highly selective agonist at kainate receptors’, J. Pharm. Exp. Ther. 285: 539-545.
41. Durand, G.M., Benett, M.V. and Zukin, R.S. (1993) ‘Splice variants of the N-methyl-D-aspartate receptor NR1 identify domains involved in regulation by polyamines and protein kinase C’, Proc. Natl. Acad. Sci. USA 90: 6731-6735.
42. Evans, R.H., Francis, A.A., Jones, A.W., Smith, D.A.S. and Watkins, J.C. (1982) ‘The effects of a series of ω-phosphonic α-carboxylic amino acids on electrically evoked and amino acid induced responses in isolated spinal cord preparations’, Br. J. Pharmacol. 75: 65-75.
43. 2+ of amino acid-induced depolarization of spinal neurones’, Experientia 33: 489-491.
44. 2+-like selective antagonism of excitatory amino acid-induced responses by α,∈-diaminopimelic acid, D-α-aminoadipate and HA-966 in isolated spinal cord of frog and immature rat’, Brain Research 148: 536-542.
45. Fagg, G.E. and Baud, J. (1988) ‘Characterisation of NMDA receptor-ionophore complexes in the brain’, in D. Lodge (ed.) Excitatory Amino Acids in Health and Disease, Chichester: John Wiley, pp. 63-90.
46. Fagg, G.E., Olpe, H.-R., Pozza, M.F., Baud, J., Steinmann, M., Schmutz, M., Portet, C., Baumann, P., Thedinga, K., Bittiger, H., Allgeier, H., Heckendorn, R., Angst, C., Brundish, D. and Dingwall, J.G. (1990) ‘CGP 37849 and CGP 39551: novel and competitive N-methyl-D-aspartate receptor antagonists with oral activity’, Br. J. Pharmacol. 99: 791-797.
47. Ferkany, J.W., Hamilton, G.S., Patch, R.J., Huang, Z., Borosky, S.A., Bednar, D.L., Jones, B.E., Zubrowski, R., Willetts, J. and Karbon, E.W. (1993a) ‘Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1,2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist’, J. Pharm. Exp. Ther. 264: 256-264.
48. Ferkany, J.W., Willetts, J., Borosky, S.A., Clissold, D.B., Karbon, E.W. and Hamilton, G.S. (1993b) ‘Pharmacology of (2R,4R,5S)-2-amino-4,5-(1,2-cyclohexyl)-7-phosphonoheptanoic acid (NPC 17742); a selective, systemically active, competitive NMDA antagonist’, Bioorg. Med. Chem. Lett. 3: 33-38.
49. Ferrer-Montiel, A.V., Merino, J.M., Planells-Cases, R., Sun, W. and Montal, M. (1998) ‘Structural determinants of the blocker binding site in glutamate and NMDA receptor channels’, Neuropharmacology 37: 139-147.
50. Fischer, G., Mutel, V., Trube, G., Malherbe, P., Kew, J.N.C., Mohaesi, E., Heitz, M.P. and Kemp, J.A. (1997) ‘Ro 25-6981, a highly potent and selective blocker of NMDA receptors containing the NR2B subunit. Characterization in vitro’, J. Pharmacol. Exp. Ther. 283: 1285-1292.
51. Gallagher, M.J., Huang, H., Pritchett, D.R. and Lynch, D.R. (1996) ‘Interactions between ifenprodil and the NR2B subunit of the N-methyl-D-aspartate receptor’, J. Biol. Chem. 271: 9603-9611.
52. Gaoni, Y., Chapman, A.G., Parvez, N., Pook, P.C.-K., Jane D.E. and Watkins, J.C. (1994) ‘Synthesis, NMDA receptor antagonist activity, and anticonvulsant action of 1-aminocyclobutanecarboxylic acid derivatives’, J. Med. Chem. 37: 4288-4296.
53. Gill, R., Foster, A.C. and Woodruff, G.N. (1987) ‘Systemic administration of MK-801 protects against ischaemia-induced hippocampal neurodegeneration in the gerbil’, J. Neurosci. 7: 3343-3349.
54. Haack, J.A., Rivier, J., Parks, T.N., Mena, E.E., Cruz, L.J. and Olivera, B.M. (1990) ‘Conantokin-T: a gamma-carboxyglutamate containing peptide with N-methyl-D-aspartate antagonist activity’, J. Biol. Chem. 265: 6025-6029.
55. Hall, J.G., Mclennan, H. and Wheal, H.V. (1977) ‘The actions of certain amino acids on neuronal excitants’, J. Physiol. 272: 52-53P.
56. Hays, S.J., Bigge, C.F., Novak, P.M., Drummond, J.T., Bobovski, T.P., Rice, M.J., Johnson, G., Brahce, L.J. and Coughenour, L.L. (1990) ‘New and versatile approaches to the synthesis of CPP- related competitive NMDA antagonists. Preliminary structure-activity relationships and pharmacological evaluation’, J. Med. Chem. 33: 2916-2924.
57. Heckendorn, R., Allgeier, H., Baud, J., Gunzenhauser, W. and Angst, C. (1993) ‘Synthesis and binding properties of 2-amino-5-phosphono-3-pentenoic acid photoaffinity ligands as probes for the glutamate recognition site of the NMDA receptor’, J. Med. Chem. 36: 3721-3726.
58. Henderson, G., Johnson, J.W. and Ascher, P. (1990) ‘Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor’, J. Physiol. (Lond.) 430: 189-212.
59. Herrling, P.L. (1997) Excitatory Amino Acids - Clinical Results with Antagonists, London: Academic Press.
60. Hirai, H., Kirsch, J., Laube, B., Betz, H. and Kuhse, J. (1996) ‘The glycine binding site of the N-methyl-D-aspartate receptor subunit NR1: identification of novel determinants of co-agonist potentiation in the extracellular M3-M4 loop region’, Proc. Natl. Acad. Sci. USA 93: 6031-6036.
61. Honer, M., Benke, D., Laube, B., Kuhse, J., Heckendorn, R., Allgeier, H., Angst, C., Monyer, H., Seeburg, P.H., Betz, H. and Mohler, H. (1998) ‘Differentiation of glycine antagonist sites of N-methyl-D-aspartate receptor subtypes: Preferential interaction of CGP 61594 with NR1/2B receptors’, J. Biol. Chem. 273: 11,158-11,163.
62. Hood, W.F., Compton, R.P. and Monahan, J.B. (1989a) ‘D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics’, Neurosci. Lett. 98: 91-95.
63. Hood, W.F., Sun, E.T., Compton, R.P. and Monahan, J.B. (1989b) '1-Aminocyclobutane-1-carboxylate (ACBC) a specific antagonist of the N-methyl-D-aspartate receptor coupled glycine receptor’, Eur. J. Pharmacol. 161: 281-282.
64. Huettner, J.E. and Bean, B.P. (1988) ‘Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels’, Proc. Natl. Acad. Sci. USA 85: 1307-1311.
65. Hutchison, A.J., Williams, M., Angst, C., de Jesus, R., Blanchard, L., Jackson, R.H., Wilusz, E.J., Murphy, D.E., Bernard, P.S., Schneider, J., Campbell, T., Guida, W. and Sills, M.A. (1989) '4-(Phosphonoalkyl)- and 4-(Phosphonoalkenyl)-2-piperidinecarboxylic acids: synthesis, activity at N-methyl-D-aspartic acid receptors, and anticonvulsant activity’, J. Med. Chem. 32: 2171-2178.
66. Iversen, L.L. and Kemp, J.A. (1994) ‘Non-competitive NMDA antagonists as drugs’, in G.L. Collingridge. and J.C. Watkins (eds) The NMDA Receptor, Oxford: Oxford University Press, pp. 469-486.
67. Jane, D.E., Olverman, H.J. and Watkins, J.C. (1994) ‘Agonists and competitive antagonists: structure-activity and molecular modelling studies’, in G.L. Collingridge and J.C. Watkins (eds) The NMDA Receptor, Oxford: Oxford University Press, pp. 31-104.
68. Jane, D.E., Thomas, N.K., Tse, H.-W. and Watkins, J.C. (1996) ‘Potent antagonists at the L-AP4- and (1S,3S)-ACPD-sensitive presynaptic metabotropic glutamate receptors in the neonatal rat spinal cord’, Neuropharmacology 35: 1029-1035.
69. Johnson, G. and Ornstein P.L. (1996) ‘Competitive NMDA antagonists - a comprehensive analysis of molecular biological, structure activity and molecular modelling relationships’, Current Pharmaceutical Design 2: 331-356.
70. Johnson, J.W. and Ascher, P. (1987) ‘Glycine potentiates the NMDA response in cultured mouse brain neurons’, Nature (Lond.) 325: 529-531.
71. 2+ increase’, Eur. J. Pharmacol. 211: 195-202.
72. Kinney, W.A. and Garrison, D.C., European Patent Application, 1992, 496, 561 A2.
73. Kinney, W.A., Lee, N.E., Garrison, D.T., Podlesney Jr., E.J., Simmonds, J.T., Bramlett, D., Notvest, R.R., Kowal, D.M. and Tasse, R.P. (1992) ‘Bioisosteric replacement of the alpha-amino carboxylic-acid functionality in 2-amino-5-phosphonopentanoic acid yields unique 3,4-diamino-3-cyclobutene-1,2-dione containing NMDA antagonists’, J. Med. Chem. 35: 4720-4726.
74. Kleckner, N.W. and Dingledine, R. (1988) ‘Requirement for glycine in activation of NMDA receptors expressed in Xenopus oocytes’, Science 241: 835-837.
75. Kotlinska, J. and Liljequist, S. (1996) ‘Oral administration of glycine and polyamine receptor antagonists blocks ethanol withdrawal seizures’, Psychopharmacology 127: 238-244.
76. Kulagowski, J.J., Baker, R., Curtis, N.R., Leeson, P.D., Mawer, I.M., Moseley, A.M., Ridgill, M.P. Rowley, M., Stansfield, I., Foster, A.C., Grimwood, S., Hill, R.G., Kemp, J.A., Marshall, G.R., Saywell, K.L. and Tricklebank, M.D. (1994) '3'-(Arylmethyl)- and 3'-(Aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: orally active antagonists of the glycine site of the NMDA receptor’, J. Med. Chem. 37: 1402-1405.
77. Kutsuwada, T., Kashiwabuchi, N., Mori, H., Sakimura, K., Kushiya, E., Araki, K., Meguro, H., Masaki, H., Kumanishi, T., Arakawa, M. and Mishina, M. (1992) ‘Molecular diversity of the NMDA receptor channel’, Nature (Lond.) 358: 36-41.
78. Kyle, D.J., Patch, R.J., Karbon, E.W. and Ferkany, J.W. (1992) ‘NMDA receptors: heterogeneity and agonism’, in P. Krogsgaard-Larsen and J.J. Hansen (eds) Excitatory Amino Acid Receptors. Design of Agonists and Antagonists, Chichester: Ellis Horwood Ltd, pp. 121-162.
79. Lanthorn, T.H., Hood, W.F., Watson, G.B., Compton, R.P., Rader, R.K., Gaoni, Y. and Monahan, J.B. (1990) ‘cis-2,4-methanoglutamate is a potent and selective N-methyl-D-aspartate receptor agonist’, Eur. J. Pharmacol. 182: 397-404.
80. Laube, B., Hirai, H., Sturgess, M., Betz, H. and Kuhse, J. (1997) ‘Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit’, Neuron 18: 493-503.
81. Laube, B., Kuhse, J. and Betz, H. (1998) ‘Evidence for a tetrameric structure of recombinant NMDA receptors’, J. Neurosci. 18: 2954-2961.
82. Leeson, P.D., Baker, R., Carling, R.W., Curtis, N.R., Moore, K.W., Williams, B.J., Foster, A.C., Donald, A.E., Kemp, J.A. and Marshall, G.R. (1991) ‘Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-D-aspartate receptor’, J. Med. Chem. 34: 1243-1252.
83. Leeson, P.D., Carling, R.W., James, K., Smith, J.D., Moore, K.W., Wong, E.H.F. and Baker, R. (1990) ‘Role of hydrogen bonding in ligand interaction with the N-methyl-D-aspartate receptor ion channel’, J. Med. Chem. 33: 1296-1305.
84. Leeson, P.D., Carling, R.W., Moore, K.W., Moseley, A.M., Smith, J.D., Stevenson, G., Chan, T., Baker, R., Foster, A.C., Grimwood, S., Kemp, J.A., Marshall, G.R. and Hoogsteen, K. (1992) '4-Amido-2-carboxytetrahydroisoquinolines. Structure-activity relationships for antagonism of the glycine site of the NMDA receptor’, J. Med. Chem. 35: 1954-1968.
85. Leeson, P.D. and Iversen, L.L. (1994) ‘The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential’, J. Med. Chem. 37: 4053-4067.
86. Leeson, P.D., Williams, B.J., Rowley, M., Moore, K.W., Baker, R., Kemp, J.A., Priestly, T., Foster, A.C. and Donald, E.A. (1993) ‘Derivatives of 1-hydroxy-3-aminopyrrolidin-2-one (HA-966). Partial agonists at the glycine site of the NMDA receptor’, Bioorg. Med. Chem. Lett. 3: 71-76.
87. Lehmann, J., Hutchison, A.J., McPherson, S.E., Mondadori, C., Schmutz, M., Sinton, C.M., Tsai, C., Murphy, D.E., Steel, D.J., Williams, M., Cheney, D.L. and Wood, P.L. (1988) ‘CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist’, J. Pharmacol. Exp. Ther. 246: 65-75.
88. Li, J.-H., Bigge, C.F., Williamson, R.M., Borosky, S.A., Vartanian, M.G. and Ortwine, D.F. (1995) ‘Potent, orally-active, competitive N-methyl-D-aspartate (NMDA) receptor antagonists are substrates for a neutral amino-acid-uptake system in Chinese-hamster ovary cells’, J. Med. Chem. 38: 1955-1965.
89. Lipton, S.A. (1993) ‘Prospects for clinically tolerated NMDA antagonists: open channel blockers and alternative redox states of nitric oxide’, Trends Neurosci. 16: 527-532.
90. Lodge, D. and Johnson, K.M. (1990) ‘Noncompetitive excitatory amino acid antagonists’, Trends Pharm. Sci. 11: 81-86.
91. Lunn, W.H.W., Schoepp, D.D., Calligaro, D.O., Vasileff, R.T., Heinz, L.J., Salhoff, C.R. and O’Malley, P.J. (1992) ‘D, L-Tetrazol-5-ylglycine, a highly potent NMDA agonist: its synthesis and NMDA receptor efficacy’, J. Med. Chem. 35: 4608-4612.
92. Marvizon, J.C.G., Lewin, A.H. and Skolnick, P. (1989) '1-Aminocyclopropane carboxylic acid: a potent and selective ligand for the glycine modulatory site of the N-methyl-D-aspartate receptor complex’, J. Neurochem. 52: 992-994.
93. Mayer, M.L., Benveniste, M. and Patneau, D.K. (1994) ‘NMDA receptor agonists and competitive antagonists’, in G.L. Collingridge and J.C. Watkins (eds) The NMDA Receptor, Oxford: Oxford University Press, pp. 132-146.
94. Meldrum, B.S. (1985) ‘Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters’, Clinical Science 68: 113-122.
95. Mena, E.E., Gullak, M.F., Pagnozzi, M.J., Richter, K.E., Rivier, J., Cruz, L.J. and Olivera, B.M. (1990) ‘Conantokin-G: a novel peptide antagonist to the N-methyl-D-aspartic acid (NMDA) receptor’, Neurosci. Lett. 118: 241-244.
96. Monaghan, D.T. and Beaton, J.A. (1992) ‘Pharmacologically-distinct NMDA receptor populations of the cerebellum, medial thalamic nuclei, and forebrain’, Mol. Neuropharm. 2: 71-75.
97. Monaghan, D.T., Bridges, R.J. and Cotman, C.W. (1989) ‘The excitatory amino acid receptors: their classes, pharmacology and distinct properties in the function of the central nervous system’, Ann. Rev. Pharmacol. Toxicol. 29: 365-402.
98. Monaghan, D.T. and Larsen, H. (1997) ‘NR1 and NR2 subunit contributions to N-methyl-D- aspartate receptor channel blocker pharmacology’, J. Pharmacol. Exp. Ther. 280: 614-620.
99. Monahan, J.B., Hood, W.F., Compton, R.P., Cordi, A.A., Snyder, J.P., Pellicciari, R. and Natalina, B. (1990) ‘Characterisation of D-3,4-cyclopropylglutamates as N-methyl-D-aspartate receptor agonists’, Neuroscience Letters 112: 328-332.
100. 3H]glutamate recognition site in synaptic plasma membranes’, J. Neurochem. 48: 1699-1708.
101. Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B. and Seeburg, P.H. (1992) ‘Heteromeric NMDA receptors: molecular and functional distinction of subtypes’, Science 256: 1217-1221.
102. Mott, D.D., Doherty, J.J., Zhang, S., Washburn, M.S., Fendley, M.J., Lyuboslavsky, P., Traynelis, S.F. and Dingledine, R. (1998) ‘Enhancement of proton inhibition: A novel mechanism of inhibition of NMDA receptors by phenylethanolamines’, Nat. Neurosci. 1: 659-667.
103. Müller, W., Lowe, D.A., Neijt, H., Urwyler, S., Herrling, P.L., Blaser, D. and Seebach, D. (1992) ‘Synthesis and N-methyl-D-aspartate (NMDA) antagonist properties of the enantiomers of α-amino-5-(phosphonomethyl)[1,1'-biphenyl]-3-propanoic acid. Use of a new chiral glycine derivative’, Helv. Chim. Acta 75: 855-864.
104. 3H]-CGS 19755: a novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brain’, Br. J. Pharmacol. 95: 932-938.
105. 3H]Ro 25-6981, a potent and selective antagonist of NMDA receptors containing NR2B subunits’, J. Neurochem. 70: 2147-2155.
106. Nagata, R., Tanno, N., Kodo, T., Ae, N., Yamaguchi, H., Nishimura, T., Antoku, F., Tatsuno, T., Kato, T., Tanaka, Y. and Nakamura, M. (1994) ‘Tricyclic quinoxalinediones: 5,6-dihydro-1H-pyrrolo[1,2,3-de]quinoxaline-2,3-diones and 6,7-dihydro-1H,5H-pyrido[1,2,3-de]quinoxaline-2,3-diones as potent antagonists for the glycine binding site of the NMDA receptor’, J. Med. Chem. 37: 3956-3968.
107. Nielsen, K.J., Skjærbæk, N., Dooley, M., Adams, D.A., Mortensen, M., Dodd, P.R., Craik, D.J., Alewood, P.F. and Lewis, R.J. (1999) ‘Structure-activity studies of conantokins as human N-methyl-D-aspartate receptor modulators’, J. Med. Chem. 42: 415-426.
108. N receptor antagonists: amino acid derivatives’, J. Med. Chem. 42: 2266-2271.
109. 3H]-D-AP5 binding in rat brain membranes’, Neuroscience 26: 17-31.
110. 3H]-D-AP5 binding sites in rat brain membranes’, Nature (Lond.) 307: 460-462.
111. 3H]-CPP, a new competitive ligand for NMDA receptors’, Eur. J. Pharmacol. 131: 161-162.
112. Ornstein, P.L., Arnold, M.B., Lunn, W.H.W., Heinz, L.J., Leander, J.D., Lodge, D. and Schoepp, D.D. (1998) ‘Heteroatom-substitution as a strategy for increasing the potency of competitive NMDA antagonists’, Bioorg. Med. Chem. Lett. 8: 389-394.
113. Ornstein, P.L. and Klimkowski, V.J. (1992). ‘Competitive NMDA receptor antagonists’, in P. Krogsgaard-Larsen and J.J. Hansen (eds) Excitatory Amino Acid Receptors. Design of Agonists and Antagonists, Chichester: Ellis Horwood Ltd, pp. 183-201.
114. Ornstein, P.L., Schoepp, D.D., Arnold, M.B., Augenstein, N.K., Lodge, D., Millar, J.D., Chambers, J., Campbell, J., Paschal, J.W., Zimmerman D.M. and Leander, J.D. (1992) '6-substituted decahydroisoquinoline-3-carboxylic acids as potent and selective conformationally constrained NMDA receptor antagonists’, J. Med. Chem. 35: 3547-3560.
115. Ortwine, D.F., Malone, T.C., Bigge, C.F., Drummond, J.T., Humblet, C., Johnson, G. and Pinter, G.W. (1992) ‘Generation of N-methyl-D-aspartate agonist and competitive antagonist pharmacophore models. Design and synthesis of phosphonoalkyl-substituted tetrahydroisoquinolines as novel antagonists’, J. Med. Chem. 35: 1345-1370.
116. Parsons, C.G., Danysz, W. and Quack, G. (1999) ‘Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - a review of preclinical data’, Neuropharmacology 38: 735-767.
117. Parsons, C.G., Danysz, W., Hartmann, S., Bartmann, A., Gold, M., Kalvinch, I., Piskunova, I. and Rozhkov, E. (1996) ‘Novel antagonists of the glycine site of the NMDA receptor: electrophysiological and biochemical characterisation’, Poster presented at the 26th Annual Meeting of the Society for Neuroscience, Washington, USA, 16-21 November.
118. Parsons, C.G., Danysz, W., Quack, G., Hartmann, S., Lorenz, B., Baran, L., Przegalinski, E., Kostowski, W., Krzascik, P., Headley, P.M., Chizh, B. (1997) ‘Novel antagonists of the glycine site of the NMDA receptor. Electrophysiological, biochemical and behavioural characterisation’, J. Pharmacol. Exp. Ther. 283: 1264-1275.
119. Parsons, C.G., Quack, G., Bresink, I., Baran, L., Przegalinski, E., Kostowski, W., Krzascik, P., Hartmann, S. and Danysz, W. (1995) ‘Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo’, Neuropharmacology 34: 1239-1258.
120. Potschka, H., Löscher, W., Wlaz, P., Behl, B., Hofmann, H.P., Treiber, H.-J. and Szabo, L. (1998) ‘LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy’, Br. J. Pharmacol. 125: 1258-1266.
121. Priestly, T., Marshall, G.R., Hill, R.G. and Kemp, J.A. (1998) ‘L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective’, Br. J. Pharmacol. 124: 1767-1773.
122. 3H]MK-801 binding to the N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines’, J. Neurochem. 51: 830-836.
123. Rock, D.M. and Macdonald, R.L. (1992) ‘Spermine and related polyamines produce a voltagedependent reduction of N-methyl-D-aspartate receptor single channel conductance’, Mol. Pharmacol. 42: 157-164.
124. Rock, D.M. and Macdonald, R.L. (1995) ‘Polyamine regulation of N-methyl-D-aspartate receptor channels’, Annu. Rev. Pharmacol. Toxicol. 35: 463-482.
125. 2+ and channel blockers by a single amino acid substitution in the N-methyl-D-aspartate receptor’, J. Biol. Chem. 268: 410-415.
126. Salituro, F.G., Harrison, B.L., Baron, B.M., Nyce, P.L., Stewart, K.T., Kehne, J.H., White, H.S. and McDonald, I.A. (1992) '3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site’, J. Med. Chem. 35: 1791-1799.
127. 3H]ifenprodil, a novel NMDA antagonist, to a polyamine-sensitive site in the rat cerebral cortex’, Eur. J. Pharmacol. 176: 249-250.
128. Schoepp, D.D., Smith, C.L., Lodge, D., Millar, J.D., Leander, J.D., Sacaan, A.I. and Lunn, W.H.W. (1991) ‘D, L-Tetrazol-5-ylglycine: a novel and highly potent NMDA receptor agonist’, Eur. J. Pharmacol. 203: 237-243.
129. Shuto, S., Ono, S., Imoto, H., Yoshi, K. and Matsuda, A. (1998) ‘Synthesis and biological activity of conformationally restricted analogues of milnacipran: (1S,2R)-1-phenyl-2-[(R)-1-amino-2-propynyl]-N, N-diethylcyclopropanecarboxamide is a novel class of NMDA receptor channel blocker’, J. Med. Chem. 41: 3507-3514.
130. 3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain’, Eur. J. Pharmacol. 192: 19-24.
131. Skolnick, P., Boje, K., Miller, R., Pennington, M. and Maccecchini, M.-L. (1992) ‘Noncompetitive inhibition of N-methyl-D-aspartate by conantokin-G: evidence for an allosteric interaction at polyamine sites’, J. Neurochem. 59: 1516-1521.
132. Sunter, D.C., Edgar, G.E., Pook, P.C.-K., Howard, J.A.K., Udvarhelyi, P.M. and Watkins, J.C. (1991) ‘Actions of the four isomers of 1-aminocyclopentane-1,3-dicarboxylate (ACPD) in the hemisected spinal cord of the neonatal rat’, Br. J. Pharmacol. (Proc. Suppl.) 104: 377P.
133. Tamiz, A.P., Whittemore, E.R., Zhou, Z.-L., Huang, J.-C., Drewe, J.A., Chen, J.-C., Cai, S.-X., Weber, E., Woodward, R.M. and Keana, J.F.W. (1998a) ‘Structure-activity relationships for a series of bis-(phenylalkyl)amines: potent subtype-selective inhibitors of N-methyl-D-aspartate receptors’, J. Med. Chem., 41: 3499-3506.
134. Tamiz, A.P., Whittemore, E.R., Schelkun, R.M., Yuen, P.-W., Woodward, R.M., Cai, S.-X., Weber, E. and Keana, J.F.W. (1998b) ‘N-(2-(4-hydroxyphenyl)ethyl)-4-chlorocinnamide: a novel antagonist at the 1A/1B NMDA receptor subtype’, Bioorg. Med. Chem. Lett. 8: 199-200.
135. Tamiz, A.P., Whittemore, E.R., Woodward, R.M., Upasani, R.B. and Keana, J.F.W. (1999) ‘Structure-activity relationship for a series of 2-substituted 1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indoles: potent subtype-selective inhibitors of N-methyl-D-aspartate (NMDA) receptors’, Bioorg. Med. Chem. Lett. 9: 1619-1624.
136. Urwyler, S., Laurie, D., Lowe, D.A., Meier, C.L. and Müller, W. (1996a) ‘Biphenyl-derivatives of 2-amino-7-phosphonoheptanoic acid, a novel class of potent competitive N-methyl-D-aspartate receptor antagonists - I. Pharmacological characterization in vitro’, Neuropharmacology 35: 643-654.
137. Urwyler, S., Campbell, E., Fricker, G., Jenner, P., Lemaire, M., McAllister, K.H., Neijt, H.C., Park, C.K., Perkins, M., Rudin, M., Sauter, A., Smith, L., Wiederhold, K.H. and Müller, W. (1996b) ‘Biphenyl-derivatives of 2-amino-7-phosphonoheptanoic acid, a novel class of potent competitive N-methyl-D-aspartate receptor antagonists - II. Pharmacological characterization in vivo’, Neuropharmacology 35: 655-669.
138. Watkins, J.C. (1962) ‘The synthesis of some acidic amino acids possessing neuropharmacological activity’, J. Med. Pharm. Chem. 5: 1187-1199.
139. Watson, G.B., Hood, W.F., Monahan, J.B. and Lanthorn, T.H. (1988) ‘Kynurenate antagonizes actions of N-methyl-D-aspartate through a glycine sensitive receptor’, Neurosci. Res. Commun. 2: 169-174.
140. Watson, G.B. and Lanthorn, T.H. (1990) ‘Pharmacological characteristics of cyclic homologues of glycine at the N-methyl-D-aspartate receptor-associated glycine site’, Neuropharmacology 29: 727-730.
141. B sites’, Eur. J. Pharmacol. 347: 183-187.
142. Whitten, J.P., Baron, B.M., Miller, D.M.F., White, H.S. and McDonald, I.A. (1990) '(R)-4-Oxo-5-phosphononorvaline: A new competitive glutamate antagonist at the NMDA receptor complex’, J. Med. Chem. 33: 2961-2963.
143. Whitten, J.P., Muench, D., Cube, R.V., Nyce, P.L., Baron, B.M. and McDonald, I.A. (1991) ‘Synthesis of 3(S)-phosphonoacetyl-2(R)-piperidine-carboxylic acid, a conformationally-restricted glutamate antagonist’, Bioorg. Med. Chem. Lett. 1: 441-444.
144. Williams, K. (1993) ‘Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: polyamine-like and high-affinity antagonist actions’, J. Pharmacol. Exp. Ther. 266: 231-236.
145. Williams, K. (1995) ‘Pharmacological properties of recombinant N-methyl-D-aspartate (NMDA) receptors containing the epsilon 4 (NR2D) subunit’, Neurosci. Lett. 184: 181-184.
146. Williams, K., Zappia, A.M., Pritchett, D.B., Shen, Y.M. and Molinoff, P.B. (1994) ‘Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits’, Mol. Pharmacol. 45: 803-809.
147. Williams, M., Kowaluk, E.A. and Arneric, S.P. (1999) ‘Emerging molecular approaches to pain therapy’, J. Med. Chem. 42: 1481-1500.
148. Wong, E.H.F., Kemp, J.A., Priestley, T., Knight, A.R., Woodruff, G.N. and Iversen, L.L. (1986) ‘The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist’, Proc. Nat. Acad. Sci. USA 83: 7104-7108.
149. Wright, J.L., Gregory, T.F., Bigge, C.F., Boxer, P.A., Serpa, K., Meltzer, L.T., Wise, L.D., Cai, S.X., Hawkinson, J.E., Konkoy, C.S., Whittemore, E.R., Woodward, R.M. and Zhou, Z.-L. (1999) ‘Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(arylalkynyl)-4-benzylpiperidines’, J. Med. Chem. 42: 2469-2477.
150. Zhou, L.-M., Szendrei, G.I., Fossom, L.H., Maccecchini, M.-L., Skolnick, P. and Otvos, Jr., L. (1996) ‘Synthetic analogues of conantokin-G: NMDA antagonists acting through a novel polyamine-coupled site’, J. Neurochem. 66: 620-628.